ESC Premium Access

Impact of COVID-19 pandemics upon pulmonary hypertension patients: insights from BNP-PL national database

Congress Session

About the speaker

Doctor Aleksandra Mamzer

Bieganski Hospital, Medical University of Lodz, Lodz (Poland)
0 follower

4 more presentations in this session

Major arterial and venous thromboembolic complications in patients with covid-19

Speaker: Associate Professor N. Lalor (Buenos Aires, AR)

Thumbnail

The coronavirus disease 2019 pandemic among adult congenital heart disease patients: findings of a one-year multicentric, international study

Speaker: Doctor F. Ruperti Repilado (Bern, CH)

Thumbnail

Comparison of echocardiographic parameters of patients with COVID-19 pneumonia in hospital and three months after discharge

Speaker: Doctor E. Yaroslavskaya (Tyumen, RU)

Thumbnail

Increased incidence of Persistent Pulmonary Hypertension of the Newborn following third trimester maternal COVID-19 infection.

Speaker: Doctor A. Ishqeir (Jerusalem, IL)

Thumbnail

Access the full session

SARS-CoV-2 in pulmonary circulation: does it do as much harm as in the alveoli?

Speakers: Doctor A. Mamzer, Associate Professor N. Lalor, Doctor F. Ruperti Repilado, Doctor E. Yaroslavskaya, Doctor A. Ishqeir
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

24-month results and technical approach of catheter-based renal denervation in patients with resistant hypertension

27 August 2021

ESC Premium Access

Heart failure as a complication of covid-19 infection: systematic review and meta-analysis

27 August 2021

ESC Premium Access

Cardiovascular protection by combination of the selective nonsteroidal MR antagonist finerenone and the SGLT2 inhibitor empagliflozin in a preclinical model of hypertension-induced end-organ damage

27 August 2021

This platform is supported by

logo Novo Nordisk